F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comGlobal Health Ltd is one of India’s leading healthcare service providers, best known for operating the Medanta hospital network. The company delivers multi-specialty medical services, including cardiology, oncology, neurology, and organ transplants, serving both domestic and international patients.
India’s healthcare sector is expanding rapidly due to rising income levels, increasing health awareness, and growing medical tourism. In this context, the Global Health Ltd Share Price Target from 2026 to 2030 is gaining attention among investors looking for exposure to the healthcare growth story. With strong infrastructure and brand value, the company is well-positioned for steady long-term growth.
| Year | Estimated Share Price Target (₹) |
|---|---|
| 2026 | 1,250 – 1,450 |
| 2027 | 1,450 – 1,700 |
| 2028 | 1,700 – 2,000 |
| 2029 | 2,000 – 2,350 |
| 2030 | 2,350 – 2,800 |
| Metric | Value |
|---|---|
| Open | ₹1,105.55 |
| Previous Close | ₹1,105.55 |
| High | ₹1,153.20 |
| Low | ₹1,102.10 |
| 52 Week High | ₹1,456.50 |
| 52 Week Low | ₹956.00 |
| Market Cap | ₹30,919 Cr |
| Volume | 103,895 |
| VWAP | ₹1,134.67 |
| Book Value Per Share | ₹144.12 |
| Dividend Yield | Not Available |
| Beta | 0.60 |
| Face Value | ₹2 |
| All Time High | ₹1,513.90 |
| All Time Low | ₹390.55 |
Global Health Ltd operates a network of multi-specialty hospitals under the Medanta brand. The company provides advanced medical care across various specialties and has built a reputation for high-quality healthcare services.
With a market cap of ₹30,919 crore, Global Health Ltd falls under the mid-to-large healthcare segment, offering a balance between growth and stability.
The book value per share is ₹144.12, indicating that the stock trades at a premium due to growth expectations and brand strength.
A beta of 0.60 suggests low volatility, meaning the stock is relatively stable compared to the broader market.
| Category | Holding (%) |
|---|---|
| Promoters | 33.01% |
| Foreign Institutions | 27.86% |
| Retail & Others | 24.36% |
| Mutual Funds | 13.91% |
| Domestic Institutions | 0.85% |
The company is continuously adding new hospitals and increasing bed capacity, which can boost revenue.
Growing population and lifestyle diseases are increasing demand for quality healthcare services.
India is becoming a global hub for affordable healthcare, benefiting companies like Global Health Ltd.
Focus on high-end treatments improves margins and profitability.
Adoption of digital healthcare and advanced medical equipment enhances efficiency and patient outcomes.
Hospital expansion requires heavy investment, which can impact cash flow.
Healthcare is a highly regulated sector, and policy changes may affect operations.
Intense competition from established hospital chains.
Managing multiple hospitals efficiently can be complex.
Government regulations on treatment costs can impact margins.
By 2026, the company is expected to benefit from increasing patient footfall and operational efficiency.
Investment Outlook: Stable growth with moderate upside potential.
In 2027, expansion plans and brand strength may contribute to higher revenues.
Investment Outlook: Positive outlook with steady earnings growth.
By 2028, the company may see significant growth due to scaling operations.
Investment Outlook: Strong growth phase with increasing profitability.
In 2029, the company’s investments may start delivering higher returns.
Investment Outlook: Attractive for long-term investors.
By 2030, the company is expected to become a dominant player in India’s healthcare sector.
Investment Outlook: Suitable for long-term wealth creation with moderate risk.
Global Health Ltd offers a compelling opportunity for investors looking to invest in the healthcare sector. While the business is capital-intensive, the long-term demand for healthcare services in India provides a strong growth foundation.
The stock may be suitable for:
The Global Health Ltd Share Price Target from 2026 to 2030 suggests steady growth backed by expanding healthcare demand, hospital network expansion, and strong brand positioning. While risks exist, the company’s long-term outlook remains positive due to structural growth in the healthcare sector.
The estimated target for 2026 is ₹1,250 to ₹1,450.
The projected target for 2030 ranges between ₹2,350 and ₹2,800.
It can be a good long-term investment for those seeking exposure to the growing healthcare sector.
Key factors include hospital expansion, patient volume, regulatory changes, and overall healthcare demand.
Currently, dividend yield data is not available, suggesting limited or no dividend payouts.
This article is for educational purposes only and should not be considered as financial or investment advice. Investors are advised to conduct their own research or consult a financial advisor before making any investment decisions.
Register & Login